Results 171 to 180 of about 629,954 (346)
Effect of point application therapy for bronchial asthma: a multicenter randomized controlled trial. [PDF]
Huanfang XU +15 more
europepmc +1 more source
Combined IVIg and 500 mg/day IVMP achieve superior efficacy over monotherapies in anti‐LGI1 encephalitis, with optimal safety. Higher‐dose IVMP (1000 mg) accelerates response but increases adverse events, particularly in diabetic patients. Cognitive deficits persist post‐treatment, necessitating long‐term management.
Yao Tan +6 more
wiley +1 more source
Analysis of current family management style and influencing factors in young children with bronchial asthma. [PDF]
Ye Y, Wang Y, Xu HZ.
europepmc +1 more source
Genetic Contribution to Asthma Informs Acute Chest Syndrome Pathophysiology and Risk Stratification
ABSTRACT Acute chest syndrome (ACS) is a severe complication of sickle cell disease (SCD) occurring in ~50% of patients, some presenting frequent episodes. We lack tools to identify patients at high risk of ACS occurrence or frequent episodes. Epidemiological studies have found an association between asthma and ACS, but whether this link is causal is ...
Sara El Aouhel +10 more
wiley +1 more source

